L
Lexeo Therapeutics, Inc. Common Stock
LXEO · NASDAQ · Healthcare · 380M
Closing price
$3.23
+0.62% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
0.7×
Enterprise value / EBITDAEV/EBITDA
-1.2×
Free cash flow yieldFCF yield
-57.1%
Return on equityROE
-40.5%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.6×
Interest coverage
-530.4×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.